Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin a in HIV-1-exposed infants in Kenya

Clinical and Experimental Immunology

Volumn 153, Issue 1, 2008, Pages 37-43

  Farquhar, C ^a   Vancott, T ^b   Bosire, R ^d   Bermudez, C ^c   Mbori Ngacha, D ^d   Lohman Payne, B ^a,d   Nduati, R ^d   Otieno, P ^d   John Stewart, G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Immunoglobulin A; Mother to child HIV 1 transmission; Saliva

Indexed keywords

GLYCOPROTEIN GP 160; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ZIDOVUDINE;

ADULT; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INFANT; KENYA; PERINATAL PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; SALIVA ANALYSIS; VAGINAL DELIVERY; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; BREAST FEEDING; CASE-CONTROL STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; KENYA; LONGITUDINAL STUDIES; RISK; RNA, VIRAL; SALIVA; VIRAL LOAD;

EID: 44949171781     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03664.x     Document Type: Article

References (33)

1. Farquhar C, John-Stewart G. The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression. Clin Exp Immunol 2003 134 : 367 77.
2. Huang YT, Wright A, Gao X, Kulick L, Yan H, Lamm ME. Intraepithelial cell neutralization of HIV-1 replication by IgA. J Immunol 2005 174 : 4828 35.
3. Devito C, Hinkula J, Kaul R et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 2000 14 : 1917.
4. Devito C, Hinkula J, Kaul R et al. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J Acquir Immune Defic Syndr 2002 30 : 413 20.
5. Moja P, Tranchat C, Tchou I et al. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J Infect Dis 2000 181 : 1607 13.
6. Archibald D, Johnson J, Nair P et al. Detection of salivary immunoglobulin A antibodies to HIV-1 in infants and children. AIDS 1990 4 : 417 20.
7. Artenstein A, VanCott T, Sitz K et al. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J Infect Dis 1997 175 : 265 71.
8. Matsuda S, Oka S, Honda M, Takebe Y, Takemori T. Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages. Scand J Immunol 1993 38 : 428 34.
9. Yasuda S, Iwasaki M, Oka S et al. Detection of HIV-gag p24-specific antibodies in sera and saliva of HIV-1- infected adults and in sera of infants born to HIV-1-infected mothers. Microbiol Immunol 1998 42 : 305 11.
10. Stark K, Warnecke C, Brinkmann V, Gelderblom H, Bienzle U, Pauli G. Sensitivity of HIV antibody detection in saliva. Med Microbiol Immunol 1993 182 : 147 51.
11. Wilson C. Developmental immunology and role of host defenses in neonatal susceptibility. In : Remington J, Klein J, ed. Infectious diseases of the fetus and newborn infant, 6th edn. Philadelphia, PA : WB Saunders Company, 2005 : 37 49.
12. Johnson DC, McFarland EJ, Muresan P et al. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. J Infect Dis 2005 192 : 2129 33.
13. Farquhar C, VanCott TC, Mbori-Ngacha DA et al. Salivary secretory leukocyte protease inhibitor (SLPI) is associated with reduced breastmilk HIV-1 transmission. J Infect Dis 2002 186 : 1173 6.
14. Farquhar C, Rowland-Jones S, Mbori-Ngacha D et al. Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission. AIDS Res Hum Retroviruses 2004 20 : 692 7.
15. Beyrer C, Artenstein AW, Rugpao S et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 1999 179 : 59 67.
16. Emery S, Bodrug S, Richardson BA et al. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000 38 : 2688 95.
17. Panteleeff DD, Emery S, Richardson BA et al. Validation of the performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay for genital swabs and breastmilk samples. J Clin Microbiol 2002 40 : 3929 37.
18. Rousseau CM, Nduati RW, Richardson BA et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003 187 : 741 7.
19. Panteleeff DD, John G, Nduati R et al. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999 37 : 350 3.
20. Mestecky J, Jackson S. Reassessment of the impact of mucosal immunity in infection with HIV and design of relevant vaccines. J Clin Immun 1994 14 : 259 67.
21. Archibald D, Herbert C. Salivary antibodies to HIV-1 in a phase 1 AIDS vaccine trial. J AIDS 1990 3 : 954 8.
22. Sakaue G, Hiroi T, Nakagawa Y et al. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. J Immunol 2003 170 : 495 502.
23. Bukawa H, Sekigawa K, Hamajima K et al. Neutralization of HIV-1 by secretory IgA induced by oral immunisation with a new macromolecular multi-component peptide vaccine candidate. Nat Med 1995 1 : 681 4.
24. Beyrer C, Artenstein A, Rugpao S et al. Epidemiologic and biologic characterization of a cohort human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. J Infect Dis 1999 179 : 59 67.
25. Kaul R, Trabattoni D, Bwayo J et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1998 13 : 23 9.
26. Mazzoli S, Trabattoni D, Lo Caputo S et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nature Med 1997 3 : 1250 7.
27. Mestecky J, Jackson S, Moldoveanu Z et al. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res Hum Retroviruses 2004 20 : 972 88.
28. Ben-Hur E, Chan WS, Yim Z et al. Photochemical decontamination of red blood cell concentrates with the silicon phthalocyanine PC 4 and red light. Dev Biol (Basel) 2000 102 : 149 55.
29. Mokili JL, Connell JA, Parry JV, Green SD, Davies AG, Cutting WA. How valuable are IgA and IgM anti-HIV tests for the diagnosis of mother-child transmission of HIV in an African setting? Clin Diagn Virol 1996 5 : 3 12.
30. Quinn TC, Kline RL, Halsey N et al. Early diagnosis of perinatal HIV infection by detection of viral-specific IgA antibodies. JAMA 1991 266 : 3439 42.
31. Schupbach J, Tomasik Z, Jendis J, Boni J, Seger R, Kind C. IgG, IgM, and IgA response to HIV in infants born to HIV-1 infected mothers. Swiss Neonatal HIV Study Group. J Acquir Immune Defic Syndr 1994 7 : 421 7.
32. Schupbach J, Wunderli W, Kind C, Kernen R, Baumgartner A, Tomasik Z. Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by Western blot. AIDS 1989 3 : 583 9.
33. Weiblen BJ, Lee FK, Cooper ER et al. Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet 1990 335 : 988 90.